Skip to main content

Table 3 Patient demographics for primary total hip and knee arthroplasty

From: Application of thrombelastography (TEG) for safety evaluation of tranexamic acid in primary total joint arthroplasty

THA

Multiple-dose TXA (N = 65)

Single-dose TXA (N = 128)

P value

Age (years)

65.52 ± 14.30

64.84 ± 14.16

0.754

Gender (male/female)

29/36

54/74

0.761

Height (m)

1.62 ± 0.69

1.60 ± 0.07

0.087

Weight (kg)

61.38 ± 9.36

58.74 ± 10.14

0.095

BMI (kg/m2)

23.49 ± 3.26

22.94 ± 3.62

0.327

Drink

20/65

29/128

0.294

Smoke

21/65

28/128

0.161

Diagnosis

 AVN

20

34

0.816

 DDH

13

28

 FNF

20

46

 ITF

2

6

 OA

6

9

 RA

3

5

 FAI

1

0

 ASA grade

2.50 ± 0.72

2.38 ± 0.65

0.215

 Operated side (left/right)

29/36

74/54

0.094

 Operation time (min)

84.00 ± 29.32

80.34 ± 30.71

0.428

 Length of hospital stay

14.63 ± 7.08

14.93 ± 9.01

0.816

 Postoperative hospital stay

8.65 ± 6.49

9.27 ± 8.15

0.595

TKA

Multiple-dose TXA (N = 70)

Single-dose TXA (N = 96)

P value

Age (years)

68.33 ± 7.40

67.28 ± 8.53

0.411

Gender (male/female)

11/59

26/70

0.092

Height (m)

1.57 ± 0.06

1.58 ± 0.06

0.542

Weight (kg)

63.19 ± 9.44

60.97 ± 9.68

0.157

BMI (kg/m2)

25.66 ± 3.34

24.48 ± 3.92

0.057

Diagnosis

 OA

66

83

0.244

 RA

4

11

 GA

0

2

 ASA grade

2.27 ± 0.48

2.17 ± 0.52

0.176

 Operated side (left/right)

36/34

36/60

0.083

 Operation time (min)

94.61 ± 28.07

95.54 ± 28.63

0.836

 Length of hospital stay

14.87 ± 8.16

14.98 ± 6.60

0.925

 Postoperative hospital stay

8.49 ± 7.40

8.94 ± 5.51

0.653

  1. ASA American Society of Anesthesiologists physical status classification system, AVN avascular necrosis, BMI body mass index, DDH developmental dysplasia of the hip, FAI femoroacetabular impingement, FNF femoral neck fracture, GA gout arthritis, ITF intertrochanteric fracture, OA osteoarthritis, RA rheumatoid arthritis, THA total hip arthroplasty, TKA total knee arthroplasty, TXA tranexamic acid